ChemicalBook > CAS DataBase List > Combretastatin A4 phosphate disodium salt

Combretastatin A4 phosphate disodium salt

Product Name
Combretastatin A4 phosphate disodium salt
CAS No.
168555-66-6
Chemical Name
Combretastatin A4 phosphate disodium salt
Synonyms
CA4P;Fosbretabulin (disodiuM);CoMbretastatin A4 disodiuM;Fosbretabulin disodiuM salt;Combretastatin A-4 phosphate;Fosbretabulin disodiuM (CA4P);Fosbretabulin disodium (CA 4DP);CoMbretastatin A4 Phosphate(CA4P);CA-4P, Combretastatin A-4 phosphate;Combretastatin A4 phosphate disodium
CBNumber
CB2496827
Molecular Formula
C18H19O8P.2Na
Formula Weight
440.29
MOL File
168555-66-6.mol
More
Less

Combretastatin A4 phosphate disodium salt Property

Melting point:
238-242 ºC
storage temp. 
-20°C
solubility 
H2O: soluble5mg/mL, clear
form 
powder
color 
white to beige
InChIKey
VXNQMUVMEIGUJW-XNOMRPDFSA-L
CAS DataBase Reference
168555-66-6
More
Less

Safety

WGK Germany 
3
HS Code 
2919.90.3000
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

TCI Chemical
Product number
C3009
Product name
Combretastatin A4 Phosphate Disodium Salt
Purity
>98.0%(HPLC)
Packaging
20mg
Price
$235
Updated
2024/03/01
TCI Chemical
Product number
C3009
Product name
Combretastatin A4 Phosphate Disodium Salt
Purity
>98.0%(HPLC)
Packaging
100mg
Price
$703
Updated
2024/03/01
Cayman Chemical
Product number
10007415
Product name
Combrestatin A4 3'-O-Phosphate (sodium salt)
Purity
≥98%
Packaging
1mg
Price
$37
Updated
2024/03/01
Cayman Chemical
Product number
10007415
Product name
Combrestatin A4 3'-O-Phosphate (sodium salt)
Purity
≥98%
Packaging
5mg
Price
$81
Updated
2024/03/01
Cayman Chemical
Product number
10007415
Product name
Combrestatin A4 3'-O-Phosphate (sodium salt)
Purity
≥98%
Packaging
10mg
Price
$142
Updated
2024/03/01
More
Less

Combretastatin A4 phosphate disodium salt Chemical Properties,Usage,Production

Description

Combretastatin A4 phosphate disodium salt, also known as fosbretabulin disodium or CA4P, is a microtubule destabilizing drug, a water-soluble prodrug of combretasain a4(ca4) and a tumor vascular-targeting agent.microtubule is the cylindrical and filamentous structure that required for cell shape, migration, cilia and flagella mobility etc. tubulin is the major component of microtubulesin proliferative endothelial cells, ca4p (dose less than 1/10 of the max. tolerated dose) leaded to tumor vascular shutdown, and short drug exposure of ca4p caused significant long-term anti-proliferative and cytotoxic effects. [1] in ca40 treated endothelia cell, myosin light chain was phosphorylated and lead to actinomyosin contractility, assembly of actin stress fibers and focal adhesions formation. [2] in huvec cells, ca4p blocked growth factor–induced endothelial cell proliferation and migration and impaired capillary tube formation. [3]in c57bl/6 mice, ca4p treatment in combination with mab against ve-cardherin facilitated b16 melanoma tumor necrosis and inhibited tumor neoangionesis. [3] in human breast cancer models in vivo, 6 hours after ca4p administration showed a 93% decreased functional vascular volume and lasted over the next 12 hours. [1]

Chemical Properties

White Solid

Preparation

Combretastatin A-4 phosphate can be synthesized by phosphorylation of combretastatin A-4 (I) following several related strategies. Direct phosphorylation of (I) employing either bis(2,2,2-trichloroethyl) phosphorochloridate in pyridine (1,2) or dibenzyl phosphite in the presence of CCl4 and DMAP (3-5) furnishes the corresponding bis-trichloroethyl (IIa) and dibenzyl (IIb) phosphate esters, which are subsequently deprotected to combretastatin A-4 phosphate (III) by either reductive trichloroethyl group cleavage with zinc dust and acetic acid (1,2) or by debenzylation with chlorotrimethylsilane/sodium iodide (3-5). Alternatively, phosphitylation of (I) using di-tert-butyl N,N- diethylphosphoramidite (3,4,6) or bis(trimethylsilylethyl) N,N-diisopropylphosphoramidite (3-5) in the presence of tetrazole yields the phosphite esters (IVa) and (IVb), respectively, which are further oxidized to the corresponding phosphates (Va) and (Vb) using m-chloroperbenzoic acid in CH2Cl2/THF (3-6). Combretastatin A-4 phosphate (III) is then obtained by acidic cleavage of the tert-butyl ester (Va) with trifluoroacetic acid (3,4,6) or trifluoromethanesulfonic acid (6), or by tetrabutylammonium fluoride-promoted cleavage of the trimethylsilylethyl ester (Vb) (3-5).

Biochem/physiol Actions

Fosbretabulin disodium (Combretastatin A4 disodium phosphate, CA4P) is a potent vascular-disrupting agent (VDA). Fosbretabulin disodium is a prodrug that is converted to combretastatin A inside the endothelial cells that line blood vessels, where it binds to tubulin dimers and prevents microtubule polymerization, resulting in mitotic arrest and apoptosis in endothelial cells. Fosbretabulin disodium is a potent anti-cancer agent that exhibits antivascular effects on tumor vasculature, inducing a rapid reduction in tumor blood flow and a concomitant increase of cellular necrosis. Some of its activity is believed to involve interference with vascular endothelial-cadherin signaling in addition to its microtubule-disrupting activity.

Mode of action

Combretastatin A4 disodium phosphate works by quickly interrupting the blood supply to tumors, resulting in tumor death due to lack of oxygen and nutrients. Its mechanism of action in treating tumors is distinct from general cytotoxic chemotherapy drugs and drugs that inhibit the formation of new blood vessels. Unlike these drugs, Compradine Disodium Phosphate targets and breaks down the immature endothelial cells of newly formed blood vessels during tumor growth, while having no effect on the mature endothelial cells of normal tissue blood vessels.

References

[1] dark gg, hill sa, prise ve, tozer gm, pettit gr, chaplin dj. combretastatin a-4, an agent that displays potent and selective toxicity toward tumor vasculature. cancer res. 1997 may 15;57(10):1829-34.
[2] KANTHOU C, TOZER G M. The tumor vascular targeting agent combretastatin A-4-phosphate induces reorganization of the actin cytoskeleton and early membrane blebbing in human endothelial cells.[J]. Blood, 2002, 99 6: 2060-2069. DOI:10.1182/BLOOD.V99.6.2060.
[3] VINCENT L, KERMANI P, YOUNG L M, et al. Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling.[J]. The Journal of clinical investigation, 2005, 115 11: 2992-3006. DOI:10.1172/JCI24586.
[4] PRABHU S, HARRIS F, LEA R W, et al. Small-molecule clinical trial candidates for the treatment of glioma.[J]. Drug discovery today, 2014, 19 9: 1298-1308. DOI:10.1016/j.drudis.2014.02.007.
[5] TOCHINAI R, NAGATA Y, ANDO M, et al. Combretastatin A4 disodium phosphate-induced myocardial injury[J]. Journal of Toxicologic Pathology, 2016, 29: 163-171. DOI:10.1293/tox.2016-0012.
[6] PATTERSON D M, RUSTIN G J S, SERRADELL N, et al. Combretastatin A-4 phosphate[J]. Drugs of The Future, 2007, 32: 1025. DOI:10.1358/DOF.2007.032.12.1158960.

Combretastatin A4 phosphate disodium salt Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Combretastatin A4 phosphate disodium salt Suppliers

MedChemexpress LLC
Tel
021-58955995
Fax
609-228-5909
Email
sales@medchemexpress.cn
Country
United States
ProdList
4861
Advantage
58
AdooQ BioScience, LLC
Tel
+1 (866) 930-6790
Fax
+1 (866) 333-9607
Email
info@adooq.com
Country
United States
ProdList
2782
Advantage
58
Target molecule Corp.
Tel
857-239-0968
Fax
857-239-8801
Email
service1@targetmol.com
Country
United States
ProdList
2559
Advantage
60
Musechem
Tel
+1-800-259-7612
Fax
+1-800-259-7612
Email
info@musechem.com
Country
United States
ProdList
4660
Advantage
60
TargetMol Chemicals Inc.
Tel
+1-781-999-5354 +1-00000000000
Email
marketing@targetmol.com
Country
United States
ProdList
32165
Advantage
58
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6391
Advantage
58
BOC Sciences
Tel
+1-631-485-4226
Fax
1-631-614-7828
Email
inquiry@bocsci.com
Country
United States
ProdList
19553
Advantage
58
Aladdin Scientific
Tel
+1-+1(833)-552-7181
Email
sales@aladdinsci.com
Country
United States
ProdList
57505
Advantage
58
TargetMol Chemicals Inc.
Tel
Email
support@targetmol.com
Country
United States
ProdList
38632
Advantage
58
United States Biological
Tel
--
Fax
--
Email
sales@advtechind.com
Country
United States
ProdList
6075
Advantage
58
ApexBio Technology
Tel
--
Fax
--
Email
sales@apexbt.com
Country
United States
ProdList
6251
Advantage
58
Medical Isotopes
Tel
--
Fax
--
Email
stohler@medicalisotopes.com
Country
United States
ProdList
6181
Advantage
68
Cayman Chemical Company
Tel
--
Fax
--
Email
cayman@caymanchem.com
Country
United States
ProdList
6213
Advantage
81
United States Biological
Tel
--
Fax
--
Email
chemicals@usbio.net
Country
United States
ProdList
6214
Advantage
80
MedChemExpress
Tel
--
Fax
--
Email
sales@medchemexpress.com
Country
United States
ProdList
6398
Advantage
58
Combi-Blocks Inc.
Tel
--
Fax
--
Email
sales@combi-blocks.com
Country
United States
ProdList
6618
Advantage
69
Riedel-de Haen AG
Tel
--
Fax
--
Country
United States
ProdList
6773
Advantage
87
TCI America
Tel
--
Fax
--
Email
sales@tciamerica.com
Country
United States
ProdList
6909
Advantage
75
MedKoo Biosciences
Tel
--
Fax
--
Email
sale@medkoo.com
Country
United States
ProdList
86
Advantage
50
Selleck Chemicals LLC
Tel
--
Fax
--
Email
info@selleckchem.com
Country
United States
ProdList
824
Advantage
60
Fragmenta
Tel
--
Fax
--
Email
sales@fragmenta.com
Country
United States
ProdList
1068
Advantage
0
More
Less

View Lastest Price from Combretastatin A4 phosphate disodium salt manufacturers

Hebei Yanxi Chemical Co., Ltd.
Product
Combretastatin A4 disodium phosphate 168555-66-6
Price
US $0.00/kg
Min. Order
1kg
Purity
0.99
Supply Ability
20 tons
Release date
2023-11-14
Hebei Weibang Biotechnology Co., Ltd
Product
Combretastatin A4 disodium phosphate 168555-66-6
Price
US $30.00-10.00/KG
Min. Order
50KG
Purity
99%
Supply Ability
500000kg
Release date
2024-10-25
PNP Biotech Co. Ltd
Product
Combretastatin A4 disodium phosphate (CA4P) 168555-66-6
Price
US $0.00/kg
Min. Order
25kg
Purity
98%
Supply Ability
Inquiry
Release date
2022-10-25

168555-66-6, Combretastatin A4 phosphate disodium saltRelated Search:


  • Combrestatin A4 3'-O-Phosphate (sodium salt)
  • Fosbretabulin disodiuM (CA4P)
  • CoMbretastatin A4 Phosphate(CA4P)
  • Phenol, 2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]-, 1-(dihydrogen phosphate), sodium salt (1:2)
  • 2-Methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl disodium phosphate
  • Combretastatin A4 phosphate disodium
  • SODIUM (Z)-2-METHOXY-5-(3,4,5-TRIMETHOXYSTYRYL)PHENYL PHOSPHATE
  • Combretastatin A-4 phosphate
  • CA-4P, Combretastatin A-4 phosphate
  • 2-Methoxy-5-[(1Z)-2-(3,4,5-triMethoxyphenyl)ethenyl]phenol 1-(Dihydrogen phosphate) SodiuM Salt
  • CoMbretastatin A4 disodiuM
  • Fosbretabulin (disodiuM)
  • Fosbretabulin disodiuM salt
  • Fosbretabulin (CoMbretastatin A4 Phosphate (CA4P)) DisodiuM
  • disodium,[2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl] phosphate
  • 2-Methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenol dihydrogen phosphate disodium salt
  • COMBRETASTATIN A-4 PHOSPHATE, DISODIUM SALT
  • CA4P
  • Combretastatin A4 disodium phosphate
  • Combretastatin A4 disodium phosphate USP/EP/BP
  • 168555-66-6 COMBRETASTATIN A4 DISODIUM PHOSPHATE (CA4P) CAS 222030-63-9
  • [2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl] phosphate
  • Disodium (Z)-2-methoxy-5-(3,4,5-trimethoxystyryl)phenyl phosphate
  • Fosbretabulin disodium (CA 4DP)
  • Combretastatin A4 Impurity 1 Disodium
  • isodium,[2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]phosphate
  • 168555-66-6
  • C18H19Na2O8P
  • C18H21Na2O8P
  • C18H19O8P2Na
  • Aromatics
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • Phosphorylating and Phosphitylating Agents
  • Inhibitors,Pharmaceuticals
  • Inhibitors
  • Combretastatin
  • All Inhibitors